Early identification of mild cognitive impairment using incomplete random forest-robust support vector machine and FDG-PET imaging
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 01, 2017
- Source ID
- 10.1016/j.compmedimag.2017.01.001
Entities
People
- David Dagan Feng
- Michael Fulham
- Shen Lu
- Weidong Cai
- Yong Xia
Organizations
- AbbVie
- Alzheimer's Association
- Alzheimer's Disease Neuroimaging Initiative
- Alzheimer's Drug Discovery Foundation
- BioClinica
- Biogen
- Bristol-Myers Squibb
- Canadian Institutes of Health Research
- Chiron Corporation
- Eli Lilly and Company
- GE HealthCare
- Hoffmann-La Roche
- Innogenetics
- Johnson & Johnson
- Laboratoires Servier
- Lundbeck
- Merck & Co.
- Meso Scale Diagnostics (United States)
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Pfizer
- Roche (United States)
- Takeda Pharmaceutical Company
- United States Department of Defense